Biological therapies in Crohn's disease: are they cost-effective? A critical appraisal of model-based analyses.
about
Ustekinumab for the treatment of Crohn's disease.The global burden of IBD: from 2015 to 2025.A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business.Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis.Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls.Cost-Effectiveness Analysis of Crohn's Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist.Economic Evaluations of Treatments for Inflammatory Bowel Diseases: A Literature Review.
P2860
Q30390909-F74B525B-4D5E-48B2-8DA7-0C4673A89E63Q38577572-1D726A89-F13A-4273-8E95-D0336AF25335Q38937842-754717BB-4927-4F83-A3E6-FF14024B4252Q38950429-C6CC47A2-92E0-4E0E-9C94-EDD141E253AFQ39316824-FB076AF7-2A74-4FA4-A770-C4C5F78F77C6Q52581473-F8C4003E-4301-4EED-81C7-21D069B228ECQ55690473-2709DCEB-1647-4752-BFEF-3D7B2697D675
P2860
Biological therapies in Crohn's disease: are they cost-effective? A critical appraisal of model-based analyses.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Biological therapies in Crohn' ...... aisal of model-based analyses.
@en
type
label
Biological therapies in Crohn' ...... aisal of model-based analyses.
@en
prefLabel
Biological therapies in Crohn' ...... aisal of model-based analyses.
@en
P2860
P1476
Biological therapies in Crohn' ...... aisal of model-based analyses.
@en
P2093
Monia Marchetti
Nicola Lucio Liberato
P2860
P304
P356
10.1586/14737167.2014.957682
P577
2014-09-27T00:00:00Z